VA
BLFS

Vident Advisory’s BioLife Solutions BLFS Stock Holding History

Vident Advisory’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$773K Buy
27,362
+7,533
+38% +$176K 0.01% 1122
2026
Q1 		$378K Buy
+19,829
New +$438K ﹤0.01% 1387

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vident Advisory's BLFS Position: Q2 2026 in Review

Vident Advisory increased its BioLife Solutions (BLFS) stake by 38% in Q2 2026, buying an estimated $176K and bringing the position to 27,362 shares worth $773K. The position accounts for 0.01% of the portfolio, ranked #1122.

Vident Advisory first reported a position in BLFS in Q1 2026 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Vident Advisory held 27,362 shares of BioLife Solutions worth $773K as of Q2 2026.
  • Vident Advisory bought 7,533 BioLife Solutions shares in Q2 2026, an estimated $176K.
  • BioLife Solutions made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1122 holding.
  • Vident Advisory first reported a position in BioLife Solutions in Q1 2026 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.